Related Experiment Video
Updated: Jul 9, 2025
28:13
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
33.4K
Percutaneous Left Atrial Appendage Occlusion-Current Evidence and Future Directions.
Johannes Rotta Detto Loria1, Steffen Desch1, Janine Pöss1
1Department of Cardiology, Heart Center Leipzig at University of Leipzig, 04289 Leipzig, Germany.
Journal of Clinical Medicine
|December 9, 2023
Summary
Percutaneous left atrial appendage occlusion (LAAO) is a safe alternative to oral anticoagulation for stroke prevention in atrial fibrillation (AF) patients at high risk. This review evaluates LAAO
Area of Science:
- Cardiology
- Interventional Cardiology
- Medical Devices
Background:
- Atrial fibrillation (AF) poses a significant stroke risk.
- Oral anticoagulation (OAC) is standard but carries bleeding risks.
- Left atrial appendage occlusion (LAAO) emerged as an alternative.
Purpose of the Study:
- To systematically review percutaneous LAAO for stroke prevention in AF.
- To evaluate anatomical considerations, patient selection, and procedural aspects.
- To assess complications, post-procedural care, and outcomes.
Main Methods:
- Systematic literature review.
- Analysis of anatomical variations and patient criteria.
- Evaluation of procedural techniques and safety data.
- Review of contemporary outcome studies.
Main Results:
- LAAO is a viable alternative to OAC in select AF patients.
- Successful occlusion rates are high with low complication rates.
- Patient selection and procedural planning are crucial for optimal outcomes.
- Long-term data confirm efficacy and safety.
Conclusions:
- Percutaneous LAAO is an effective stroke prevention strategy for high-risk AF patients.
- Comprehensive understanding of anatomy and procedural nuances optimizes results.
- LAAO offers a valuable therapeutic option reducing reliance on OAC.
